Oligodendrogenesis in the normal and pathological central nervous system

B El Waly, M Macchi, M Cayre, P Durbec - Frontiers in neuroscience, 2014 - frontiersin.org
Oligodendrocytes (OLGs) are generated late in development and myelination is thus a
tardive event in the brain developmental process. It is however maintained whole life long at …

[HTML][HTML] Mechanism-based approaches of 1, 3, 4 thiadiazole scaffolds as potent enzyme inhibitors for cytotoxicity and antiviral activity

D Kumar, H Kumar, V Kumar, A Deep, A Sharma… - Medicine in Drug …, 2023 - Elsevier
Significant progress in understanding cancer pathogenesis, it remains one of the leading
causes of death after cardiovascular diseases. Similarly viral infections have emerged from …

[PDF][PDF] Collaborative study report on blood coagulation factor IX: Expert Committee on Biological Standardization: Geneva, 12 to 16 October 2015

World Health Organization… - 2015 - apps.who.int
There are three main aims for this collaborative study: 1. to add a FIX antigen value to the 4
th International Standard for Blood Coagulation Factors II, VII, IX and X, Plasma, Human …

Dimethyl fumarate selectively reduces memory T cells and shifts the balance between Th1/Th17 and Th2 in multiple sclerosis patients

QI Wu, Q Wang, G Mao, CA Dowling… - The Journal of …, 2017 - journals.aai.org
Dimethyl fumarate (DMF; trade name Tecfidera) is an oral formulation of the fumaric acid
ester that is Food and Drug Administration approved for treatment of relapsing-remitting …

How I manage Evans syndrome and AIHA cases in children

M Miano - British journal of haematology, 2016 - Wiley Online Library
Summary The management of Evans Syndrome in children is challenging due to the lack of
evidence‐based data on treatment. Steroids, the first‐choice therapy, are successful in …

The neurobiology of HIV and its impact on cognitive reserve: A review of cognitive interventions for an aging population

SL Cody, DE Vance - Neurobiology of disease, 2016 - Elsevier
The medications used to treat HIV have reduced the severity of cognitive deficits; yet, nearly
half of adults with HIV still exhibit some degree of cognitive deficits, referred to as HIV …

[PDF][PDF] John Cunningham virus: an overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy

V Pietropaolo, C Prezioso, F Bagnato… - New …, 2018 - newmicrobiologica.org
JCV is a small (∼ 45 nm), non-enveloped, circular, double-stranded DNA genome,
arranged in 72 viral capsomeres with icosahedral symmetry (Tan et al., 2009a). The genome …

Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS)

J Bauer, R Gold, O Adams, H Lassmann - Acta neuropathologica, 2015 - Springer
Progressive multifocal leukoencephalopathy is a viral encephalitis induced by the John
Cunningham (JC) virus, an ubiquitous neurotropic papovavirus of the genus polyomavirus …

Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis

R Hoepner, S Faissner, A Salmen… - Journal of central …, 2014 - journals.sagepub.com
Natalizumab (Nat) is a humanized monoclonal antibody used for the treatment of relapsing
multiple sclerosis (MS). Nat inhibits lymphocyte migration via the blood brain barrier (BBB) …

CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS

V Limmroth, F Barkhof, N Desem, MP Diamond… - Neurology, 2014 - AAN Enterprises
Objective: This study evaluated the efficacy and safety of ATL1102, an antisense
oligonucleotide that selectively targets the RNA for human CD49d, the α subunit of very late …